Cleared Special

K092527 - NEXUS INJECTION SITE, MODEL NIS-8

K092527 is an FDA 510(k) clearance for NEXUS INJECTION SITE, manufactured by Nexus Medical, LLC. The device is a Class 2 General Hospital device with product code FPA cleared through the Special 510(k) pathway after a 170-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2010
Decision
170d
Days
Class 2
Risk

K092527 is an FDA 510(k) clearance for the NEXUS INJECTION SITE, MODEL NIS-8. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Nexus Medical, LLC (Lenexa, US). The FDA issued a Cleared decision on February 4, 2010 after a review of 170 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K092527

510(k) Number K092527 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2009
Decision Date February 04, 2010
Days to Decision 170 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d slower than avg
Panel avg: 129d · This submission: 170d
Pathway characteristics
Modification to existing cleared device.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 1177
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K092527.
NEXUS INTRAVASCULAR TUBING SETS-PRE-PIERCED
K092930 · Nexus Medical, LLC · Mar 2010
AMSINO I.V. ADMINISTRATION SET, AMSAFE3 I.V ADMINISTRATION SET, EXTENSION SETS
K093773 · Amsino International, Inc. · Mar 2010
AUTOSTART BURETTE
K092905 · Analytica Pty, Ltd. · Mar 2010
EXTENSION SET (STANDARDBORE TUBING), EXTENSION SET (MINIBORE TUBING), IV ADMINISTRATION SET ( STANDARD
K093271 · Victus, Inc. · Jan 2010
EXEL I.V. EXTENSION SET
K092172 · Exelint Intl. Co. · Jan 2010
DISPOSABLE TPE INFUSION SET
K090459 · Shan Dong Wei Gao Group Medical Polymer Products · Oct 2009